1 / 1

Medtech Pulse Check, by the Numbers

Every week, LSIu2019s Market Intelligence team dives into a different topic shaping the future of medical technology. From disruptive startups to fast-growing device segments, we connect the dots between clinical demand, market dynamics, and innovation pipelines. Hereu2019s what the LSI Market Intelligence team tracked this past month across electrophysiology (EP), transcatheter mitral valve replacement (TMVR), and the U.S. and APAC medtech markets. For more information visit here: https://www.lifesciencemarketresearch.com/insights/medtech-pulse-check-by-the-numbers<br>

George125
Download Presentation

Medtech Pulse Check, by the Numbers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medtech Pulse Check, by the Numbers Every week, LSI’s Market Intelligence team dives into a different topic shaping the future of medical technology. From disruptive startups to fast-growing device segments, we connect the dots between clinical demand, market dynamics, and innovation pipelines. Here’s what the LSI Market Intelligence team tracked this past month across electrophysiology (EP), transcatheter mitral valve replacement (TMVR), and the U.S. and APAC medtech markets. Rewiring the Rhythm: Breakthroughs in Electrophysiology Heart rhythm disorder management is entering a new era. Once dominated by basic monitoring tools like the surface ECG, EP now encompasses a robust ecosystem of AI-powered diagnostics, leadless pacemakers, non-invasive ablation technologies, and real-time navigation software. Today, over 1.5 million pacemaker implantation procedures and 1.4 million cardiac ablation procedures are performed annually. Demand is growing, driven by technological refinement, an aging global population, and rising awareness of arrhythmias like atrial fibrillation (AFib). Disruptive Players Redefining EP AccurKardia CEO: Juan Jimenez Stage: Seed Raise to date: $3.2M Innovation: AI-driven ECG analytics for 13 heart rhythm disorders This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/medtech-pulse-check-by-the-numbers

More Related